Medical Aesthetics

market opportunity

  • The worldwide market for dermal fillers is approximately $610 million, growing at a rate of approximately 35 percent.(1)
  • Allergan’s market share in dermal fillers is approximately 28 percent.(1)
  • The worldwide market for breast aesthetics is approximately $720 million, growing at a rate of approximately 18 percent.(1)
  • Allergan’s worldwide market share in breast aesthetics is approximately 38 percent.(1)

Allergan’s Total Rejuvenation™ portfolio is where science meets beauty, featuring the most comprehensive, science-based medical aesthetic products available. Today, Allergan ranks as one of the largest companies worldwide in the medical aesthetics market. A few of our flagship aesthetic products include:

BOTOX® Cosmetic/VISTABEL®/VISTABEX® (Botulinum Toxin Type A)

In 2007, Allergan celebrated the fifth anniversary of the FDA’s approval of BOTOX® Cosmetic and, in 2007, BOTOX® Cosmetic ranked as the number-one non-surgical physician-administered aesthetic procedure in the United States.(2) BOTOX® Cosmetic is indicated for temporary improvement in the appearance of moderate to severe glabellar lines (the vertical frown lines between the eyebrows that look like an “11”) in adults ages 18-65 and is available in most regions worldwide.

JUVÉDERM™ Ultra, JUVÉDERM™ Ultra Plus

The JUVÉDERM™ family of dermal fillers contains the highest concentration of non-animal, cross-linked hyaluronic acid to provide a smooth, long-lasting correction of moderate to severe facial wrinkles and folds. Developed using the proprietary HYLACROSS™ technology, JUVÉDERM™ is the first smooth consistency gel dermal filler and currently the only hyaluronic acid dermal filler clinically proven to last for up to one year. In addition to the United States, JUVÉDERM™ is available in Canada, the European Union and Australia.

The NATRELLE™ Collection

The NATRELLE™ Collection offers women the widest range of safe and high-quality breast implant options for breast augmentation, revision and reconstructive surgery. From saline and silicone gel filler, to smooth and textured surfaces, and a range of shapes, profiles and volumes, women today have more options than ever before in breast aesthetics to achieve an individualized result based on their unique body type and surgical goals.

M.D. FORTÉ®

M.D. FORTÉ® is a comprehensive skin care line for every skin type, special needs and procedural care that provides effective products at an affordable price.

PREVAGE® MD

PREVAGE® MD anti-aging treatment is the most powerful antioxidant available to help correct present damage and protect skin from future damage with physician-strength idebenone 1%.(3)

VIVITÉ®

Launched in 2007, VIVITÉ® is Allergan’s newest skin care line. VIVITÉ® is an advanced glycolic acid and natural antioxidant system formulated with GLX Technology™ for skin rejuvenation. A scientific advancement in skin care, VIVITÉ® is clinically shown to help reduce the skin’s signs of aging in just three weeks.(4)

(1)  Mixture of public information (earnings releases, 10Ks, 10Qs), Allergan internal data, syndicated marketing research reports, analyst reports, Internet searches, competitive intelligence, etc. in U.S. dollars at actual exchange rates for 12 months ending September 2007.
(2)  The American Society for Aesthetic Plastic Surgery 2007. Cosmetic Surgery National Data Bank.
(3)  McDaniel DH, Neudecker BA, DiNardo JC, Lewis JA II, Maibach HI. Idebenone: a new antioxidant - part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants. J Cosmet Dermatol. 2005;4 (1): 10-17.
(4)  Allergan data on file.